15908227|t|The F(ab)'2 fragment of an Abeta-specific monoclonal antibody reduces Abeta deposits in the brain.
15908227|a|This work examines whether administering the F(ab' )2 fragment of an IgG1 monoclonal antibody (mAb) targeting the N-terminal 1-13 amino acids of the beta-amyloid peptide (Abeta mAb) reduces amyloid deposition in Alzheimer's disease (AD). The F(ab')2 fragment was injected intraperitoneally or intracranially into Tg2576 mice, a murine model of human AD. Both routes of administration significantly reduced Abeta plaque formation in the brain, as determined immunohistochemically and by monitoring levels of Abeta1-40 and Abeta1-42 peptide. Use of the F(ab')2 fragment significantly reduced phagocytic infiltration in the CNS when compared to intact mAb. Since IgG1 Abs do not fix complement, these findings suggest that effective in vivo clearance of amyloid deposits can be achieved without stimulation of FcR-reactive phagocytes or activation of the complement cascade.
15908227	6	8	ab	Gene	351
15908227	27	32	Abeta	Gene	351
15908227	70	75	Abeta	Gene	351
15908227	146	148	ab	Gene	351
15908227	168	172	IgG1	Gene	105243590
15908227	248	268	beta-amyloid peptide	Gene	351
15908227	270	275	Abeta	Gene	351
15908227	289	307	amyloid deposition	Disease	MESH:D058225
15908227	311	330	Alzheimer's disease	Disease	MESH:D000544
15908227	332	334	AD	Disease	MESH:D000544
15908227	343	345	ab	Gene	351
15908227	412	418	Tg2576	CellLine	CVCL:S723
15908227	419	423	mice	Species	10090
15908227	427	433	murine	Species	10090
15908227	443	448	human	Species	9606
15908227	449	451	AD	Disease	MESH:D000544
15908227	505	510	Abeta	Gene	351
15908227	652	654	ab	Gene	351
15908227	759	763	IgG1	Gene	105243590
15908227	850	866	amyloid deposits	Disease	MESH:D058225
15908227	906	909	FcR	Gene	109615
15908227	Association	MESH:D058225	351
15908227	Negative_Correlation	105243590	351
15908227	Negative_Correlation	MESH:D000544	351

